Market Tracker

03/29 4:48pm ET

Grifols SA (NASDAQ:GRFS)

18.20
Delayed Data
As of Mar 29
 +0.10 / +0.55%
Today’s Change
14.27
Today|||52-Week Range
18.50
+13.25%
Year-to-Date
Catalyst Pharmaceuticals (CPRX) Jumps: Stock Gains 18.2%
Mar 28 / Zacks.com - Paid Partner Content
Allergan's Dermal Filler for Wrinkle Correction Gets FDA Nod
Mar 21 / Zacks.com - Paid Partner Content
Who Will Win the March Madness of Trump Stocks?
Mar 23 / Zacks.com - Paid Partner Content
AstraZeneca (AZN) Gets Another CRL for ZS-9; Inks COPD Deal
Mar 20 / Zacks.com - Paid Partner Content
5 Cheap PEG Picks for Value Investors Right Now
Mar 22 / Zacks.com - Paid Partner Content
Is Grifols a Great Stock for Value Investors?
Mar 17 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close18.10
Today’s open18.11
Day’s range18.11 - 18.24
Volume624,178
Average volume (3 months)703,206
Market cap$4.6B
Dividend yield3.01%
Data as of 3:59pm ET, 03/29/2017

Growth & Valuation

Earnings growth (last year)+3.24%
Earnings growth (this year)--
Earnings growth (next 5 years)+11.95%
Revenue growth (last year)+2.94%
P/E ratio--
Price/Sales2.46
Price/Book3.15

Competitors

 Today’s
change
Today’s
% change
MNKMallinckrodt Plc+1.24+2.80%
OPKOPKO Health Inc-0.20-2.41%
IONSIonis Pharmaceutical...-0.26-0.67%
ALNYAlnylam Pharmaceutic...+0.75+1.44%
Data as of 4:14pm ET, 03/29/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)$0.24
Annual revenue (last year)$4.5B
Annual profit (last year)$602.1M
Net profit margin13.47%

Profile

Sector
Health Technology
Industry
Biotechnology
Joint Chief Executive Officer &
Director
Raimon Grifols Roura
Joint Chief Executive Officer &
Director
Victor Grifols Deu
Corporate headquarters
Barcelona, Catalonia

Forecasts